These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Aortic replacement during post chemotherapy retroperitoneal residual tumor resection for nonseminomatous germ cell tumor: a case report]. Matsuzaki M; Nakano M; Komatsu H; Ohashi K Hinyokika Kiyo; 2005 Dec; 51(12):831-4. PubMed ID: 16440734 [TBL] [Abstract][Full Text] [Related]
24. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection. Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023 [TBL] [Abstract][Full Text] [Related]
25. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia. Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765 [TBL] [Abstract][Full Text] [Related]
26. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy? Beck SD; Cheng L; Bihrle R; Donohue JP; Foster RS J Urol; 2007 Mar; 177(3):944-6. PubMed ID: 17296383 [TBL] [Abstract][Full Text] [Related]
32. Surgical aspects in the treatment of patients with testicular cancer. Richie JP Hematol Oncol Clin North Am; 1991 Dec; 5(6):1127-42. PubMed ID: 1663937 [TBL] [Abstract][Full Text] [Related]
33. Adult primary pure teratoma of the testis. The Indiana experience. Leibovitch I; Foster RS; Ulbright TM; Donohue JP Cancer; 1995 May; 75(9):2244-50. PubMed ID: 7712432 [TBL] [Abstract][Full Text] [Related]
34. Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy. Williams SB; Kacker R; Steele GS; Richie JP Urol Oncol; 2012; 30(1):60-3. PubMed ID: 20189842 [TBL] [Abstract][Full Text] [Related]
35. Evolution of the management of stage I nonseminomatous germ-cell tumors of the testis. Sogani PC Urol Clin North Am; 1991 Aug; 18(3):561-73. PubMed ID: 1652171 [TBL] [Abstract][Full Text] [Related]
36. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors? Mosharafa AA; Foster RS; Bihrle R; Koch MO; Ulbright TM; Einhorn LH; Donohue JP Cancer; 2003 Aug; 98(4):753-7. PubMed ID: 12910519 [TBL] [Abstract][Full Text] [Related]
37. Clonal origin of metastatic testicular teratomas. Jones TD; Wang M; Sung MT; Zhang S; Ulbright TM; Eble JN; Beck SD; Foster RS; Anagnostou JJ; Conner C; Cheng L Clin Cancer Res; 2006 Sep; 12(18):5377-83. PubMed ID: 16982812 [TBL] [Abstract][Full Text] [Related]
38. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings. Brown JA; Bihrle R; Foster RS Urology; 2008 May; 71(5):911-4. PubMed ID: 18342916 [TBL] [Abstract][Full Text] [Related]
39. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience. Spiess PE; Kassouf W; Brown GA; Kamat AM; Liu P; Gomez JA; Tu SM; Tannir NM; Pisters LL J Urol; 2007 Apr; 177(4):1330-4; discussion 1334. PubMed ID: 17382725 [TBL] [Abstract][Full Text] [Related]
40. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection. Ehrlich Y; Yossepowitch O; Kedar D; Baniel J BJU Int; 2006 Jun; 97(6):1221-4. PubMed ID: 16686715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]